Form 4: Quest Diagnostics Executive Catherine T. Doherty Reports Stock Transactions

EVP Catherine T. Doherty reports acquisition of restricted stock units and stock options, along with indirect disposition of shares through a company plan.

Summary

• Catherine T. Doherty, an Executive Vice President at Quest Diagnostics, filed a Form 4 detailing changes in her beneficial ownership of the company's stock.
• On February 12, 2025, Doherty acquired 3,479 shares of common stock through restricted stock units.
• On the same day, she indirectly disposed of 4,430 shares of common stock through the company's 401(k)/SDCP.
• Doherty also acquired 13,344 non-qualified stock options with an exercise price of $165.3, vesting in three equal annual installments starting February 12, 2026, and expiring on February 12, 2035.
• Following these transactions, Doherty directly owns 71,891 shares of common stock and indirectly owns 4,430 shares through the 401(k)/SDCP.
• She also holds 13,344 non-qualified stock options.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard regulatory filing detailing stock transactions. The acquisition of stock options and restricted stock units is mildly positive, while the indirect disposition is mildly negative.

Positives

• The acquisition of restricted stock units and stock options suggests confidence in the company's future performance.

Negatives

• The indirect disposition of 4,430 shares, while part of a company plan, could be interpreted as a slight reduction in her overall stake.

Risks

• Fluctuations in the market price of Quest Diagnostics stock could impact the value of Doherty's holdings.
• Changes in company performance could affect the vesting and value of the stock options.

Future Outlook

The document does not contain specific forward-looking statements, but the stock option vesting schedule suggests a multi-year commitment.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates the transactions of a high ranking executive.

Comparison to Industry Standards

• Executive compensation packages often include a mix of salary, stock options, and restricted stock units to align management's interests with those of shareholders.
• The vesting schedule of the stock options is typical for executive compensation plans.
• Comparable companies such as Laboratory Corporation of America Holdings (LH) also have executives who regularly report stock transactions via Form 4 filings.

Stakeholder Impact

• The transactions may have a minor impact on shareholder sentiment, depending on how they interpret the insider activity.
• The stock option grants incentivize the executive to improve company performance, potentially benefiting all stakeholders.

Key Dates